- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01581112
Microbial Community Transplantation on the Armpit/Foot
September 17, 2013 updated by: University Ghent
Microbial Community Transplantation on the Armpit/Foot in Order to Reduce the Malodour Generation on Armpit/Foot
The malodour generation of a person's armpit/foot is caused by the bacteria thriving on that armpit/foot.
In order to alter or reduce once bad body odour or foot odour, the living microbial community on the foot/armpit of a non-malodorous person will be transmitted (or up scaled and transmitted) to the foot/armpit of a malodorous person.
The odour is evaluated by a trained smelling panel, the bacteria living on the armpit/foot is examined by means of molecular techniques.
The microbial transplantation and its follow-up happens under the supervision of a doctor.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ghent, Belgium
- Ghent University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Bad armpit or foot odour
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Heavy armpit odour
Subjects with heavy armpit odour.
|
Every subjects has 2 armpits and 2 feet.
One armpit/foot is treated, the other is not treated.
|
Experimental: Heavy foot odour
Subjects with heavy foot odour.
|
Every subjects has 2 armpits and 2 feet.
One armpit/foot is treated, the other is not treated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and day 1
|
Odour evaluation by a trained smelling panel.
|
Baseline and day 1
|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and day 2
|
Odour evaluation by a trained smelling panel.
|
Baseline and day 2
|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and day 3
|
Odour evaluation by a trained smelling panel.
|
Baseline and day 3
|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and day 4
|
Odour evaluation by a trained smelling panel.
|
Baseline and day 4
|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and day 5
|
Odour evaluation by a trained smelling panel.
|
Baseline and day 5
|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and week 2
|
Odour evaluation by a trained smelling panel.
|
Baseline and week 2
|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and week 3
|
Odour evaluation by a trained smelling panel.
|
Baseline and week 3
|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and week 4
|
Odour evaluation by a trained smelling panel.
|
Baseline and week 4
|
Change in molecular characterisation of the bacterial community.
Time Frame: Baseline and day 1
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and day 1
|
Change in molecular characterisation of the bacterial community.
Time Frame: Baseline and day 2
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and day 2
|
Change in molecular characterisation of the bacterial community.
Time Frame: Baseline and day 3
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and day 3
|
Change in molecular characterisation of the bacterial community.
Time Frame: Baseline and day 4
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and day 4
|
Change in molecular characterisation of the bacterial community.
Time Frame: Baseline and day 5
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and day 5
|
Change in molecular characterisation of the bacterial community.
Time Frame: Baseline and week 2
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and week 2
|
Change in molecular characterisation of the bacterial community.
Time Frame: Baseline and week 3
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and week 3
|
Change in molecular characterisation of the bacterial community.
Time Frame: Baseline and week 4
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and 2 months
|
Odour evaluation by a trained smelling panel.
|
Baseline and 2 months
|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and 4 months
|
Odour evaluation by a trained smelling panel.
|
Baseline and 4 months
|
Change in odour severity after bacterial transplantation
Time Frame: Baseline and 6 months
|
Odour evaluation by a trained smelling panel.
|
Baseline and 6 months
|
Change in molecular characterisation of the bacterial community
Time Frame: Baseline and 2 months
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and 2 months
|
Change in molecular characterisation of the bacterial community
Time Frame: Baseline and 4 months
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and 4 months
|
Change in molecular characterisation of the bacterial community
Time Frame: Baseline and 6 months
|
Microbial evaluation by means of DNA extraction and Denaturing Gradient Gel Electrophoresis (DGGE).
|
Baseline and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jo Lambert, MD, PhD, University Hospital, Ghent
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
April 18, 2012
First Submitted That Met QC Criteria
April 18, 2012
First Posted (Estimate)
April 19, 2012
Study Record Updates
Last Update Posted (Estimate)
September 18, 2013
Last Update Submitted That Met QC Criteria
September 17, 2013
Last Verified
September 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- 2012/256
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heavy, Bad Body Odour From Armpit
-
University GhentUniversity Hospital, GhentCompleted
Clinical Trials on Microbial transplant
-
VA Office of Research and DevelopmentCompleted
-
University GhentUniversity Hospital, GhentCompleted
-
University of California, San DiegoCompletedAtopic Dermatitis EczemaUnited States
-
Beth Israel Deaconess Medical CenterBrigham and Women's Hospital; The Broad FoundationCompletedCrohn's DiseaseUnited States
-
Griffin HospitalYale-Griffin Prevention Research Center; Multiple Sclerosis Treatment Center...Active, not recruitingMultiple SclerosisUnited States
-
Helsinki University Central HospitalUniversity of HelsinkiActive, not recruitingFecal Microbiota Transplantation | Cesarean Section, Affecting Fetus or Newborn | Intestinal MicrobiomeFinland
-
Lawson Health Research InstituteSt. Joseph's Health Care LondonNot yet recruitingArthritis | Arthritis, Rheumatoid | Fecal Microbiota Transplantation
-
MemorialCare Health SystemMemorial Medical Center FoundationCompletedClostridium Difficile ColitisUnited States
-
Mayo ClinicCompleted
-
Joshua SternAlbert Einstein College of Medicine; University of Minnesota; Litholink CorporationNot yet recruiting